Zealand Pharma A/S at JPMorgan Healthcare Conference Transcript
Good afternoon, and welcome to the Zealand session of the 44th JPMorgan Healthcare Conference. My name is Sophia Graeff Buhl Nielsen. I'm an analyst here at JPMorgan on the European Pharma & Biotech team. And today, it's my pleasure to welcome Adam Steensberg, CEO of Zealand Pharma to the conference. (Event Instructions)
With that, over to you, Adam.
/- -
Thank you. Great to be here, and welcome, everyone. So what better way to kick start what looks to be the most exciting year in Zealand's more than 25 years history in working in metabolic health. A few weeks ago, we launched our Metabolic Frontier 2030 strategy and ambition to really go in and do our part to address what we consider as the biggest healthcare challenge of our time, and that's the obesity pandemic and all the diseases that follows the obesity pandemic.
What I will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
